Leveraging Regulatory Collaboration to Strengthen Public–Private Innovation Partnerships

The panel will examine how the Access Consortium can move beyond regulatory alignment to enable coordinated evidence generation, faster system adoption, and scaled innovation. It will highlight public–private partnerships that reduce duplication across regulatory, HTA, and real-world evidence pathways, improving predictability for market access.
Participants will explore cross-border RWE collaboration, stronger investor confidence, and positioning Access countries as a globally competitive innovation bloc. The session will also introduce Access Innovation BioBridge as a non-regulatory platform to drive these efforts and launch near-term pilot

Monday, May 4, 15:15 - 16:00, room Osaka/Samarkand

Name	Position	Institution
Jaspreet K. Grewal	Managing Partner	Access Innovation BioBridge

Name	Position	Institution
Jean-Paul Lemieux	Canadian Ambassador to Switzerland and Liechtenstein
Jörg Schläpfer	Chief of Staff and Head Sector External Relations	Swissmedic
Zara Asgharpour	Head of External Innovation	Lonza

Global Village program

This panel discussion is part of the Global Village program